Cullinan Therapeutics Boosts Investor Confidence with SLE Success & Fireside ChatsCullinan Therapeutics amps investor engagement with T‑cell engagers, sharing breakthrough SLE Phase 1b data and outlining future oncology plans.CULLINAN THERAPEUTICS INC Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated 10/11/2026, 13:12 2 minutes to read